Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Omega Healthcare InvestorsBSP:O2HI34 46 EV-to-EBIT is 7.93 as of Aug. 09, 2026, which is 67% below its 10-year median of 24.14. GuruFocus rates BSP:O2HI34 with a GF Score™ of 46/100 and a GF Value™ of R$70.35 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 656 REITs companies, Omega Healthcare Investors ranks better than 52.59% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Omega Healthcare Investors's Enterprise Value for the quarter that ended in Jun. 2026 was R$46,563 Mil.
Omega Healthcare Investors's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$5,844 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Healthcare Investors EV-to-EBIT Related Terms
Omega Healthcare Investors EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:O2HI34 vs DOC, AHR, CTRE: EV-to-EBIT Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors EV-to-EBIT vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's EV-to-EBIT falls into.
Omega Healthcare Investors's current Enterprise Value is R$46,338 Mil.
Omega Healthcare Investors's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$5,844 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Healthcare Investors (BSP:O2HI34) has a EV-to-EBIT of 7.93 as of Aug. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Omega Healthcare Investors and its competitors. This is 67% below median its historical median of 24.14. Over the past decade, Omega Healthcare Investors' EV-to-EBIT has ranged from 16.86 to 38.77. According to the industry distribution chart, Omega Healthcare Investors ranks #311 out of 656 companies in the REITs industry, placing it in the top 47.4%.
Is Omega Healthcare Investors' EV-to-EBIT too high?
Omega Healthcare Investors' current EV-to-EBIT of 7.93 is 67% below median its 10-year median of 24.14. Over the past 10 years, this metric has ranged from a low of 16.86 to a high of 38.77. The REITs industry median EV-to-EBIT is 18.11. Omega Healthcare Investors' value of 7.93 is 56.2% below this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #311 out of 656 companies in the REITs industry, which is above the industry midpoint. Overall, Omega Healthcare Investors has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' EV-to-EBIT compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #311 out of 656 companies for EV-to-EBIT. This puts Omega Healthcare Investors in the upper half of its industry. The industry median EV-to-EBIT is 18.11. Omega Healthcare Investors' value of 7.93 is 56.2% below this benchmark. Historically, Omega Healthcare Investors' own EV-to-EBIT has ranged from 16.86 to 38.77 over the past decade. While the company's 10-year median is 24.14 vs. the industry median of 18.11, Omega Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a REITs company?
The median EV-to-EBIT among REITs companies is 18.11, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current EV-to-EBIT of 7.93 is 56.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median EV-to-EBIT is 18.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current EV-to-EBIT is 7.93, which is 67% below median its own 10-year median of 24.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$70.35, compared to a current price of R$81.84 — trading 16.3% above its estimated fair value. The current EV-to-EBIT is 7.93, which is 67% below median its 10-year median of 24.14 and 56.2% below the REITs industry median of 18.11. Omega Healthcare Investors' overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current EV-to-EBIT is 7.93 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$81.84 is trading 16.3% above its estimated GF Value™ of R$70.35.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
EV-to-EBIT: 7.93 (67% below median its 10-year median of 24.14)
GF Value™: R$70.35 vs. price of R$81.84 (16.3% above fair value)
Industry Position: 56.2% below the REITs median (#311 of 656)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
46GF Score
Get the complete analysis for BSP:O2HI34
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
